Ok so who are mxc behind? Or as the tone of your post suggested well behind. What about the research through their overseas partnerships in both Europe and Israel? The research at RMIT has a specific focus. In terms of your clinical trials statement you ignore the pathway that is open to companies such as mxc. Through authorised prescribers such as prof wendyl. The same pathway tilray took as well. I think you need to do some more in depth research rather than shooting from the hip.
Ok so who are mxc behind? Or as the tone of your post suggested...
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
-0.015(3.80%) |
Mkt cap ! $17.20M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 39.5¢ | 38.0¢ | $2.163K | 5.582K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4763 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 52 | 1 |
View Market Depth
| Last trade - 15.42pm 08/05/2024 (20 minute delay) ? |
| RGT (ASX) Chart |